Filana Therapeutics, Inc.

Other · United States

Last price 0.622 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 30.05M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer’s disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The...